MAGED1 and gastric cancer: So far, NRAGE overexpression has been described as playing a role in migration and invasion of breast cancer (Wang et al., 2012), hepatocellular carcinoma (Shimizu et al., 2016), and high-grade gastric cancer (Kanda and Kodera, 2016).